E2F1 and cancer: Cyclin E can be regulated independently of E2F1 as well: cyclin E overexpression, a common event in cancer, can arise from its defective proteolysis through inactivating mutations in its E3 ubiquitin ligase Fbxw7 (Caruso et al., 2018).